{
    "name": "ivermectin topical",
    "comment": "Rx, OTC",
    "other_names": [
        "Sklice",
        "Soolantra"
    ],
    "classes": [
        "Acne Agents",
        "Topical",
        "Scabicidal Agents",
        "Pediculicides",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/sklice-soolantra-ivermectin-topical-999720",
    "pregnancy": {
        "common": [
            "There are no studies with use of in pregnant females",
            "Insufficient data available on oral use to inform a drug-associated risk of adverse developmental outcomes, because either the timing of administration during gestation was not accurately ascertained or the administration occurred only during the second trimester",
            "However, systemic exposure from topical use of ivermectin is much lower than that from oral use",
            "There is information available on the presence of ivermectin in human milk in 4 lactating women after a single 150 mcg/kg oral dose of ivermectin",
            "However, there is insufficient information to determine the effects of ivermectin on the breastfed infant or the effects of ivermectin on milk production",
            "Topical ivermectin systemic exposure is much lower than that for oral ivermectin",
            "Furthermore, the amount of ivermectin present in human milk after topical application of ivermectin to lactating women has not been studied"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Ivermectin induced adverse developmental outcomes when orally administered to pregnant mice, rats and rabbits during organogenesis only at or near doses that were maternally toxic to the pregnant females"
                ]
            },
            {
                "type": "Clinical considerations",
                "description": [
                    "Advise a lactating woman to avoid accidental transfer of topical ivermectin to breast area where the infant might directly ingest the drug"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There is information available on the presence of ivermectin in human milk in 4 lactating women after a single 150 mcg/kg oral dose of ivermectin",
            "However, there is insufficient information to determine the effects of ivermectin on the breastfed infant or the effects of ivermectin on milk production",
            "Topical ivermectin systemic exposure is much lower than that for oral ivermectin",
            "Furthermore, the amount of ivermectin present in human milk after topical application of ivermectin to lactating women has not been studied"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "To prevent ingestion, administer to children only with direct adult supervision",
                "Not for oral, ophthalmic, or intravaginal use",
                "Avoid contact with lips or eyes; wash hands following application",
                "Topical lotion is for use on scalp and scalp hair only",
                "Systemic absorption and potential for toxicity in infants <6 months may be increased due to higher surface area to body mass ration and immature skin barrier; not recommended for these patients"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Conjunctivitis",
            "percent": null
        },
        {
            "name": "Ocular hyperemia",
            "percent": null
        },
        {
            "name": "Eye irritation",
            "percent": null
        },
        {
            "name": "Dandruff",
            "percent": null
        },
        {
            "name": "Dry skin",
            "percent": null
        },
        {
            "name": "Skin burning sensation",
            "percent": null
        },
        {
            "name": "Local adverse reactions",
            "percent": null
        },
        {
            "name": "Contact dermatitis and allergic dermatitis",
            "percent": null
        }
    ]
}